Escalon Medical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023
For the six months, revenue was USD 5.81 million compared to USD 5.61 million a year ago. Net loss was USD 0.097518 million compared to USD 0.326767 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.05 a year ago. Diluted loss per share from continuing operations was USD 0.02 compared to USD 0.05 a year ago.